Yu-Tao Xiang

Yu-Tao Xiang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in The Lancet Psychiatry
Verified
Journal Article
Closed access
YXYu-Tao Xiang
Yu-Tao Xiang
YYYuan Yang
Yuan Yang
WLWen Li
Wen Li
LZLing Zhang
Ling Zhang
QZQinge Zhang
Qinge Zhang
CNChee H. Ng
Chee H. Ng

1 January 2020 in International Journal of Biological Sciences
Verified
Journal Article
Open access
WLWen Li
Wen Li
YYYuan Yang
Yuan Yang
ZLZi-Han Liu
Zi-Han Liu
YZYan-Jie Zhao
Yan-Jie Zhao
QZQinge Zhang
Qinge Zhang
YXYu-Tao Xiang
Yu-Tao Xiang
The novel coronavirus disease (COVID-19) has been rapidly transmitted in China, Macau, Hong Kong, and other Asian and European counterparts. This COVID-19 epidemic has aroused increasing attention nationwide. Patients, health professionals, and the general public are under insurmountable psychological pressure which may lead to various psychological problems, such as anxiety, fear, depression, and insomnia. Psychological crisis intervention plays a pivotal role in the overall deployment of the disease control. The National Health Commission of China has summoned a call for emergency psychological crisis intervention and thus, various mental health associations and organizations have established expert teams to compile guidelines and public health educational articles/videos for mental health professionals and the general public alongside with online mental health services. In addition, mental health professionals and expert groups are stationed in designated isolation hospitals to provide on-site services. Experts have reached a consensus on the admission of patients with severe mental illness during the COVID-19 outbreak in mental health institutions. Nevertheless, the rapid transmission of the COVID-19 has emerged to mount a serious challenge to the mental health service in China.

1 April 2020 in The Lancet Psychiatry
Verified
Journal Article
Closed access
YYYuan Yang
Yuan Yang
WLWen Li
Wen Li
QZQinge Zhang
Qinge Zhang
LZLing Zhang
Ling Zhang
TCTeris Cheung
Teris Cheung
YXYu-Tao Xiang
Yu-Tao Xiang

27 March 2020 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
HBHai-Xin Bo
Hai-Xin Bo
WLWen Li
Wen Li
YYYuan Yang
Yuan Yang
YWYu Wang
Yu Wang
QZQinge Zhang
Qinge Zhang
YXYu-Tao Xiang
Yu-Tao Xiang

2 August 2022
Verified
Journal Article
Closed access
WBWei Bai
Wei Bai
PCPan Chen
Pan Chen
HCHong Cai
Hong Cai
QZQinge Zhang
Qinge Zhang
ZSZhaohui Su
Zhaohui Su
YXYu-Tao Xiang
Yu-Tao Xiang
Background Mild cognitive impairment (MCI) is the preclinical and transitional stage between healthy ageing and dementia that may be a potential 'target' for interventions designed to delay progression to dementia. In this systematic review and meta-analysis, we assessed the prevalence of MCI worldwide in community-dwelling adults aged 50 years and older. Methods PubMed, Web of Science, Embase and PsycINFO database searches were conducted from their respective inception dates to 1 September 2021. Data on the overall prevalence of MCI were synthesised using random effects models. Results A total of 66 articles covering 242,804 participants fulfilled study criteria for inclusion. The overall prevalence of MCI was 15.56% (95%CI: 13.24-18.03%). Prevalence rates of amnestic MCI and non-amnestic MCI were 10.03% (95%CI: 7.98-12.27%) and 8.72% (95%CI: 6.78-10.89%), respectively. The prevalence of MCI increased with age and decreased with education level. Subgroup and meta-regression analyses revealed that region of study site and male gender proportion per sample were significant correlates of MCI prevalence. Conclusion The global prevalence of MCI among community dwellers is over 15% and is affected by age, gender, education level and region of study sites. Assessment and interventions targeting MCI within at-risk population subgroups should be considered toward the prevention of dementia.

2 December 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
HLHaibin Li
Haibin Li
DZDeqiang Zheng
Deqiang Zheng
ZLZhiwei Li
Zhiwei Li
ZWZhiyuan Wu
Zhiyuan Wu
WFWei Feng
Wei Feng
XGXiuhua Guo
Xiuhua Guo
Depressive symptoms are common among middle-aged and older adults.1,2 China, like much of Asia, is experiencing an increase in older adults. The prevalence of depressive symptoms in older adults has become an increasingly important public health priority.3-5 A national survey in China6 showed that approximately 30% of men and 43% of women aged 45 years and older experienced depressive symptoms. Epidemiological studies7-9 have found that depressive symptoms are associated with a range of negative health outcomes, such as coronary heart diseases, stroke, and all-cause mortality.